Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects
Ingemansson Sandra; Wickenberg Jennie; Hlebowicz Joanna · 2010 · Nutrition Journal
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract
Abstract Background Previous animal studies have shown that Curcuma (C.) longa lowers plasma glucose. C. longa may thus be a promising ingredient in functional foods aimed at preventing type 2 diabetes. The purpose of the study is to study the effect of C. longa on postprandial plasma glucose, insulin levels and glycemic index (GI) in healthy subjects. Methods Fourteen healthy subjects were assessed in a crossover trial. A standard 75 g oral glucose tolerance test (OGTT) was administered together with capsules containing a placebo or C. longa . Finger-prick capillary and venous blood samples w
Abstract by Ingemansson Sandra; Wickenberg Jennie; Hlebowicz Joanna, Nutrition Journal (2010) — licensed CC BY 4.0.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
Assessing the impact of non-tariff measures on Sri Lankan mango exports: insights, challenges, and recommendations
Negative / Null Result ReportEffects of N-acetylcysteine on aging cell and obesity complications in obese adults: a randomized, double-blind clinical trial
Negative / Null Result ReportEndothelial Progenitor Cell Levels and Extent of Post-prandial Lipemic Response
Negative / Null Result ReportEffect of glgB/GASBD fusion gene expression on increased branching degree of potato starch and changes in physicochemical properties of starch
Negative / Null Result ReportEffects of Dietary Supplementation with Moringa oleifera on HIV Viral Load in Adults Receiving Standard Care
Negative / Null Result ReportEvaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: DOAJ · DOI 10.1186/1475-2891-9-43